GRO Biosciences tackles ‘Holy Grail’ challenges, using non-standard amino acids to expand the amino acid palette Last month, GRObio completed a $25-million Series A financing co-led by Leaps by Bayer...
Read More
BOSTON--(BUSINESS WIRE)--GRO Biosciences Inc. (“GRObio”), an emerging biotechnology company leveraging groundbreaking science to expand the amino acid alphabet and deliver on the promise of protein therapeutics, today announced the appointment of...
Read More
